This is a preview. Log in through your library . Abstract Background Cost-effectiveness analyses of treatments for glioblastoma multiforme (GBM) have mostly used state transition Markov models with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback